Drug Profile
Oxycodone controlled release - Elite Pharmaceuticals
Alternative Names: ELI-154; once-a-day oxycodone - Elite Pharmaceuticals; oxycodone CR - Elite Pharmaceuticals; OxyQD™Latest Information Update: 08 Jan 2022
Price :
$50
*
At a glance
- Originator Elite Pharmaceuticals
- Class Alkaloids; Morphine derivatives; Opioid analgesics; Small molecules
- Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Pain
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 16 Feb 2012 Oxycodone controlled release is still in phase II trials for Pain in USA
- 18 Nov 2010 Development is ongoing in USA (PO)
- 18 Nov 2010 Oxycodone controlled release - Elite Pharmaceuticals is still available for licensing in Europe. http://www.elitepharma.com